Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124900873 | 12490087 | 3 | F | 20160620 | 20160622 | 20160705 | EXP | CA-CONCORDIA PHARMACEUTICALS INC.-CO-PL-CA-2016-284 | CONCORDIA | 69.00 | YR | F | Y | 0.00000 | 20160705 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124900873 | 12490087 | 1 | PS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | N | 9768 | ||||||||||
| 124900873 | 12490087 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 0 | |||||||||||
| 124900873 | 12490087 | 3 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 0 | |||||||||||
| 124900873 | 12490087 | 4 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | 0 | |||||||||||
| 124900873 | 12490087 | 5 | SS | ORENCIA | ABATACEPT | 1 | Unknown | 0 | |||||||||||
| 124900873 | 12490087 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | 0 | |||||||||||
| 124900873 | 12490087 | 7 | C | ESTROGEL | ESTRADIOL | 1 | 0 | ||||||||||||
| 124900873 | 12490087 | 8 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 124900873 | 12490087 | 9 | C | XALATAN | LATANOPROST | 1 | 0 | ||||||||||||
| 124900873 | 12490087 | 10 | C | COSOPT | DORZOLAMIDE HYDROCHLORIDETIMOLOL MALEATE | 1 | 0 | ||||||||||||
| 124900873 | 12490087 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 124900873 | 12490087 | 12 | C | VALSARTAN. | VALSARTAN | 1 | 0 | ||||||||||||
| 124900873 | 12490087 | 13 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 124900873 | 12490087 | 14 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124900873 | 12490087 | 1 | Product used for unknown indication |
| 124900873 | 12490087 | 2 | Product used for unknown indication |
| 124900873 | 12490087 | 3 | Rheumatoid arthritis |
| 124900873 | 12490087 | 4 | Product used for unknown indication |
| 124900873 | 12490087 | 5 | Product used for unknown indication |
| 124900873 | 12490087 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124900873 | 12490087 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124900873 | 12490087 | Adverse event | |
| 124900873 | 12490087 | Bronchitis | |
| 124900873 | 12490087 | C-reactive protein increased | |
| 124900873 | 12490087 | Colitis microscopic | |
| 124900873 | 12490087 | Diverticulitis | |
| 124900873 | 12490087 | Drug hypersensitivity | |
| 124900873 | 12490087 | Drug ineffective | |
| 124900873 | 12490087 | Drug intolerance | |
| 124900873 | 12490087 | Glaucoma | |
| 124900873 | 12490087 | Synovitis | |
| 124900873 | 12490087 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124900873 | 12490087 | 2 | 20130405 | 20131011 | 0 |